Form 8-K - Current report:
SEC Accession No. 0001411690-24-000060
Filing Date
2024-11-13
Accepted
2024-11-13 16:03:33
Documents
16
Period of Report
2024-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bngo-20241113.htm   iXBRL 8-K 31503
2 EX-99.1 a2024-09x30bngox3qearnings.htm EX-99.1 219443
6 picture3a.jpg GRAPHIC 3015
7 picture4a.jpg GRAPHIC 1947
  Complete submission text file 0001411690-24-000060.txt   403125

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bngo-20241113.xsd EX-101.SCH 1794
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bngo-20241113_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bngo-20241113_pre.xml EX-101.PRE 12516
18 EXTRACTED XBRL INSTANCE DOCUMENT bngo-20241113_htm.xml XML 2926
Mailing Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121
Business Address 9540 TOWNE CENTRE DRIVE SUITE 100 SAN DIEGO CA 92121 (858) 888-7600
Bionano Genomics, Inc. (Filer) CIK: 0001411690 (see all company filings)

EIN.: 261756290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38613 | Film No.: 241453914
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)